The wave of progress in the cell and gene industries, which has already made its way from the southern and central regions of China, now arrives in the historic city of Nanjing! On December 27, 2025, at No. 13, Building 16, Treehouse, 73 Tanmi Road, Jiangbei New Area, Nanjing, an industry event focusing on “Quality and Standards” will soon take place.
As the fourth stop in the Cell Chain & CCSIA Cell Standardization Industry Alliance Salon series, this event continues the success of the previous three events (held in Guangzhou Nansha, Changsha, and Shenzhen Shekou), offering a premium platform for professionals in the Yangtze River Delta’s cell industry to engage in policy discussions, technical exchanges, and resource networking.
Event Highlights
New Industry Opportunities Under Legal Regulation
On May 1, 2026, the “Regulations on the Clinical Research and Clinical Application of New Biomedical Technologies” (known as the “818 Regulations”) will come into effect. This landmark regulation is China’s first to govern emerging technologies such as stem cell and gene editing. The salon will delve into how the “818 Regulations” will impact the cell industry, explore compliant development strategies, and help businesses seize new opportunities under a regulated legal framework.
Nanjing's Growing Bio-Medical Industry Momentum
Nanjing, a key bio-pharmaceutical hub in the Yangtze River Delta, has demonstrated significant momentum in the cell and gene therapy fields, highlighted by the successful hosting of the GCS2025 Sixth International Cell and Gene Therapy Summit earlier this year. This salon will bring together a wide range of resources from both upstream and downstream sectors of the industry, providing participants with valuable opportunities for regional policy insights and business matchmaking.
Featured Products
As one of the co-hosts of the event, MSHOT will showcase two cutting-edge live cell imaging products. Stay tuned for more details!
A versatile tool for cell culture, it can be used directly within an incubator and supports phase contrast and fluorescence imaging for 6-384 well plates, culture bottles, culture dishes, and slides. The device also allows for selected region scanning and image stitching, enabling large-scale, long-duration observations. This significantly enhances experimental efficiency, especially for comparative studies, and reduces the risk of contamination and experimental failure.
This microscope supports brightfield, phase contrast, and fluorescence imaging, making it suitable for a variety of sample types. The phase ring plate on the condenser is compatible with multiple magnification objectives, producing highly detailed, three-dimensional images of transparent samples. The fluorescence system includes five standard channels (UBGYR) and can be customized to meet specific customer needs, offering tailored excitation wavelengths and channel configurations. It is widely used in cell biology research, stem cell studies, organoid research, and cell and gene therapy (CGT) applications.
Time and Location
Date: December 27, 2025
Venue: No. 13, Building 16, Treehouse, 73 Tanmi Road, Jiangbei New Area, Nanjing (Nanjing Pharmaceutical Valley)
Theme: “Rhyme of Innovation” – Nanjing Cell Quality and Industry Standardization Salon
The cell industry is entering a new era defined by “Quality and Standards.” This Nanjing salon is not only a platform for thought leadership but also an invaluable opportunity for business networking. MSHOT looks forward to collaborating with you to explore the future of the industry and work together to drive the high-quality development of the cell industry!